Chatham Lodging Trust CLDT
Institutional shares held
42.2 Million
1.7K
calls
0
puts
Total value of holdings
$355M
$14K
calls
$0
puts
Market Cap
$411M
48,806,500
Shares Out.
Institutional ownership
86.44%
# of Institutions
172
We take great care to ensure that the data presented and summarized in this overview for Chatham Lodging Trust is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CLDT
View all-
Vanguard Group Inc Valley Forge, PA5.34MShares$45 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.16MShares$43.5 Million0.0% of portfolio
-
Donald Smith & Co., Inc. New York, NY4.5MShares$37.9 Million1.0% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA2.69MShares$22.6 Million0.09% of portfolio
-
Goldman Sachs Group Inc New York, NY2.33MShares$19.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.65MShares$13.9 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.62MShares$13.6 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.23MShares$10.4 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY970KShares$8.17 Million0.0% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA970KShares$8.17 Million0.01% of portfolio
Latest Institutional Activity in CLDT
Top Purchases
Top Sells
About CLDT
Chatham Lodging Trust is a self-advised, publicly traded real estate investment trust focused primarily on investing in upscale, extended-stay hotels and premium-branded, select-service hotels. At September, 30, 2020, The company owns interests in 86 hotels totaling 12,040 rooms/suites, comprised of 40 properties it wholly owns with an aggregate of 6,092 rooms/suites in 15 states and the District of Columbia and a minority investment in the Innkeepers joint ventures that owns 46 hotels with an aggregate of 5,948 rooms/suites.
Insider Transactions at CLDT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2025
|
Robert D Perlmutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,772
+11.97%
|
$132,948
$9.14 P/Share
|
|
Jan 15
2025
|
David Grissen Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,763
+27.21%
|
$105,867
$9.14 P/Share
|
|
Jan 15
2025
|
Rolf E Ruhfus Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,754
+13.0%
|
$78,786
$9.14 P/Share
|
|
Jan 15
2025
|
Mary Elizabeth Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,754
+18.63%
|
$78,786
$9.14 P/Share
|
|
Jan 15
2025
|
Ethel Issacs Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,754
+25.58%
|
$78,786
$9.14 P/Share
|
|
Jan 15
2025
|
Edwin B Brewer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,581
+8.56%
|
$38,324
$4.57 P/Share
|
|
Jun 10
2024
|
Dennis M Craven EVP & Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+9.76%
|
$84,000
$7.88 P/Share
|
|
Jan 16
2024
|
Ethel Issacs Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,504
+28.02%
|
$65,040
$10.76 P/Share
|
|
Jan 16
2024
|
Rolf E Ruhfus Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,504
+11.55%
|
$65,040
$10.76 P/Share
|
|
Jan 16
2024
|
Edwin B Brewer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,328
+8.28%
|
$36,640
$5.38 P/Share
|
|
Jan 16
2024
|
Mary Elizabeth Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,504
+18.07%
|
$65,040
$10.76 P/Share
|
|
Jan 16
2024
|
Robert D Perlmutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,150
+10.62%
|
$111,500
$10.76 P/Share
|
|
Jan 16
2024
|
David Grissen Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,504
+24.81%
|
$65,040
$10.76 P/Share
|
|
Jun 09
2023
|
Ethel Issacs Williams Director |
SELL
Open market or private sale
|
Direct |
2,000
-16.39%
|
$18,000
$9.92 P/Share
|
|
Jun 01
2023
|
Edwin B Brewer Jr Director |
BUY
Open market or private purchase
|
Direct |
8,800
+31.88%
|
$158,400
$18.95 P/Share
|
|
Mar 17
2023
|
Dennis M Craven EVP & Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.0%
|
$9,000
$9.97 P/Share
|
|
Mar 16
2023
|
Jeffrey H Fisher Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+1.61%
|
$100,000
$10.28 P/Share
|
|
Mar 15
2023
|
Dennis M Craven EVP & Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+3.92%
|
$40,000
$10.3 P/Share
|
|
Jan 17
2023
|
Thomas J Crocker Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,623
+8.37%
|
$67,476
$12.45 P/Share
|
|
Jan 17
2023
|
Ethel Issacs Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,623
+31.54%
|
$67,476
$12.45 P/Share
|
Last 12 Months Summary
Buy / Acquisition
74.4K
Shares
From
7
Insiders
| Grant, award, or other acquisition | 62.4K shares |
|---|---|
| Open market or private purchase | 12K shares |
Sell / Disposition
0
Shares
From
0
Insiders